OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AERG.PK56

Applied Energetics Inc

Advanced Medical Equipment & TechnologyVerified

Applied Energetics operates with a highly liquid capital structure, as evidenced by $6.44 million in cash and equivalents and a current ratio of 8.29, indicating strong short-term liquidity. However, the company’s negative return on equity (-196.74%) and return on assets (-164.07%) highlight severe underperformance relative to its asset base and equity. These metrics fall far below the typical expectations for a technology firm, even in early-stage development. Profitability remains a critical challenge, with a net loss of $14.87 million and an operating loss of $14.93 million in the latest period. Gross profit of $24.91 million suggests some margin potential, but the company’s inability to convert this into positive operating results indicates operational inefficiencies or high R&D and development costs. The company’s revenue is not segmented by geography or product in the provided data, but its focus on defense platforms implies a concentration in the U.S. defense market. This exposes the company to procurement cycles and budgetary constraints within the Department of Defense, which could limit diversification and revenue stability. Growth prospects are constrained by the company’s current financial position. While it has developed proprietary directed energy technologies, the outlook for revenue and profitability remains uncertain. The absence of positive operating cash flow (-$9.24 million) and free cash flow (-$15.60 million) suggests the company is not yet self-sustaining and will require continued capital infusions. Risk factors include the company’s reliance on a narrow product portfolio and its dependence on defense contracts, which are subject to political and budgetary shifts. The risk assessment indicates low liquidity and dilution risk, but the absence of immediate flags does not preclude future capital-raising needs, particularly if R&D or commercialization efforts exceed current funding. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company’s ongoing losses and lack of positive cash flow suggest a need for close monitoring of future capital-raising activities and contract awards.

30-day price · AERG.PK(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyApplied Energetics Inc
TickerAERG.PK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Applied Energetics Inc develops and deploys fiber-based ultrashort pulse laser systems for defense and commercial applications, leveraging proprietary Laser Guided Energy and Laser Induced Plasma Channel technologies to deliver compact, high-intensity directed energy solutions.

Classification. The company is classified under industry code 5610101013 (Advanced Medical Equipment & Technology) within the Healthcare Services & Equipment business sector, with a confidence score of 0.92, though its industry alignment is Aerospace & Defense.

Applied Energetics operates with a highly liquid capital structure, as evidenced by $6.44 million in cash and equivalents and a current ratio of 8.29, indicating strong short-term liquidity. However, the company’s negative return on equity (-196.74%) and return on assets (-164.07%) highlight severe underperformance relative to its asset base and equity. These metrics fall far below the typical expectations for a technology firm, even in early-stage development. Profitability remains a critical challenge, with a net loss of $14.87 million and an operating loss of $14.93 million in the latest period. Gross profit of $24.91 million suggests some margin potential, but the company’s inability to convert this into positive operating results indicates operational inefficiencies or high R&D and development costs. The company’s revenue is not segmented by geography or product in the provided data, but its focus on defense platforms implies a concentration in the U.S. defense market. This exposes the company to procurement cycles and budgetary constraints within the Department of Defense, which could limit diversification and revenue stability. Growth prospects are constrained by the company’s current financial position. While it has developed proprietary directed energy technologies, the outlook for revenue and profitability remains uncertain. The absence of positive operating cash flow (-$9.24 million) and free cash flow (-$15.60 million) suggests the company is not yet self-sustaining and will require continued capital infusions. Risk factors include the company’s reliance on a narrow product portfolio and its dependence on defense contracts, which are subject to political and budgetary shifts. The risk assessment indicates low liquidity and dilution risk, but the absence of immediate flags does not preclude future capital-raising needs, particularly if R&D or commercialization efforts exceed current funding. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company’s ongoing losses and lack of positive cash flow suggest a need for close monitoring of future capital-raising activities and contract awards.
Key takeaways
  • Applied Energetics holds proprietary directed energy technologies with potential in defense and commercial markets but is currently unprofitable.
  • The company’s liquidity position is strong, with a current ratio of 8.29 and $6.44 million in cash, but this may not be sufficient to fund long-term operations.
  • Gross profit of $24.91 million indicates some margin potential, but operational inefficiencies are evident in the $14.93 million operating loss.
  • Revenue concentration in defense platforms and lack of geographic diversification increase exposure to procurement and budgetary risks.
  • The company’s financial outlook is constrained by negative cash flows and the need for continued capital infusions.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$461.7k
Gross profit$249.1k
Operating income-$14.9M
Net income-$14.9M
R&D
SG&A
D&A
SBC
Operating cash flow-$9.2M
CapEx-$1.2M
Free cash flow-$15.6M
Total assets$9.1M
Total liabilities$1.5M
Total equity$7.6M
Cash & equivalents$6.4M
Long-term debt$48.0k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$7.6M
Net cash$6.4M
Current ratio8.3
Debt/Equity0.0
ROA-1.6%
ROE-2.0%
Cash conversion62.0%
CapEx/Revenue-2.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Equipment · cohort 160 companies
MetricAERG.PKActivity
Op margin-3233.5%-24.0% medp25 -212.9% · p75 6.1%bottom quartile
Net margin-3221.1%-20.7% medp25 -188.5% · p75 4.8%bottom quartile
Gross margin54.0%49.8% medp25 36.6% · p75 67.4%above median
CapEx / revenue-267.4%-4.7% medp25 -11.2% · p75 -1.8%bottom quartile
Debt / equity1.0%3.6% medp25 0.0% · p75 22.2%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 16:35 UTC#ff4c3a72
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 16:37 UTCJob: 031dffcd